Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis.
Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis / Guglielmelli, P; Rotunno, G; Fanelli, T; Pacilli, A; Brogi, G; Calabresi, L; Pancrazzi, A; Vannucchi, A M. - In: BLOOD CANCER JOURNAL. - ISSN 2044-5385. - ELETTRONICO. - 5:(2015), pp. e360-e360. [10.1038/bcj.2015.90]
Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis
GUGLIELMELLI, PAOLA;ROTUNNO, GIADA;FANELLI, TIZIANA;PACILLI, ANNALISA;CALABRESI, LAURA;PANCRAZZI, ALESSANDRO;VANNUCCHI, ALESSANDRO MARIA
2015
Abstract
Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
CALR mutations.pdf
accesso aperto
Descrizione: Articolo principale
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
321.08 kB
Formato
Adobe PDF
|
321.08 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
